These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8079481)
1. [The diagnostic significance of a surface modification in the T-lymphocytes in acute leukemia]. Kindzel'skiĭ AL; Gaĭdukova SN Lik Sprava; 1993 Jul; (8):68-70. PubMed ID: 8079481 [No Abstract] [Full Text] [Related]
2. [The function of the T immunity system in patients with hemoblastoses undergoing polychemotherapy]. Zverkova AS; Bratus' GG Vrach Delo; 1991 Feb; (2):39-43. PubMed ID: 2058119 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of lymphocyte subpopulations during the remission-maintaining treatment of patients with myeloblastic leukemia]. Duraj M; Hołowiecki J; Krawczyk M; Rudzka E; Jagoda K Acta Haematol Pol; 1987; 18(1-2):28-34. PubMed ID: 3501662 [No Abstract] [Full Text] [Related]
4. [The action of antitumor preparations on the rosette-forming function of lymphocytes]. Shabalin VN; Serova LD; Rozanova OE Gematol Transfuziol; 1988 Aug; 33(8):6-12. PubMed ID: 3263931 [No Abstract] [Full Text] [Related]
5. [Large granule-containing lymphocytes in patients with acute leukemia]. Gashchuk AP; Kindzel'skiĭ AL Vrach Delo; 1989 Jul; (7):10-1. PubMed ID: 2800475 [No Abstract] [Full Text] [Related]
6. [Natural killer activity--an index of the efficacy of the treatment of patients with acute leukemia]. Gashchuk AP; Evtukh VP; Kindzel'skiĭ AL Lik Sprava; 1994; (5-6):79-81. PubMed ID: 7831919 [No Abstract] [Full Text] [Related]
7. [The efficacy of active specific immunotherapy using modified neoplastic cells in the combined modality treatment of hemoblastoses]. Zverkova AS; Bratus' GG; Darchuk GF; Komissarenko VG; Koval' AI; Tretiak NN; Gashchuk AP; Vakul'chuk AM; Ruzhinskaia EE; Dzhevadova IV Lik Sprava; 1998 Dec; (8):88-94. PubMed ID: 10204358 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells. Stahnke K; Eckhoff S; Mohr A; Meyer LH; Debatin KM Leukemia; 2003 Nov; 17(11):2130-9. PubMed ID: 14523471 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of relapsed AML and ALL]. Nishikawa K Rinsho Ketsueki; 1996 Aug; 37(8):647-50. PubMed ID: 8827871 [No Abstract] [Full Text] [Related]
10. "Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment. Arlin ZA; Feldman EJ; Finger L; Ahmed T; Mittelman A; Puccio C; Cook P; Chun HG Semin Hematol; 1991 Jul; 28(3 Suppl 4):44-7. PubMed ID: 1780752 [No Abstract] [Full Text] [Related]
11. [Immunological deficiency in patients with the myeloid forms of acute leukemia and the methods for its correction]. Gaĭdukova SN; Kindzel'skiĭ AL; Zverkova AS Lik Sprava; 1994; (9-12):78-83. PubMed ID: 7604594 [TBL] [Abstract][Full Text] [Related]
12. Acute myeloid and lymphoblastic leukemia in adults. The course of the disease in 315 patients from one region, during a ten-year period. Johnsen HE; Bergmann OJ; Ellegaard J; Bastrup-Madsen P Dan Med Bull; 1989 Apr; 36(2):189-93. PubMed ID: 2707057 [TBL] [Abstract][Full Text] [Related]
13. [Therapy of acute leukemia in adults]. Lechner K Wien Med Wochenschr; 1991; 141(9-10):180-90. PubMed ID: 1949839 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of shenqi fuzheng injection combined with chemotherapy in treatment of acute leukemia and its effect on T-lymphocyte subsets, serum IFN-gamma, IL-10 and IL-2]. Wei YF; Wang SY; Ren LL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Apr; 25(4):303-6. PubMed ID: 15892271 [TBL] [Abstract][Full Text] [Related]
15. [Study on efficacy of treatment of acute leukemia by shengfu injection in combination with chemotherapy and the effect on cellular immunity, serum interleukin-6 and tumor necrosis factor-alpha levels]. Wei YF; Du HL; Wang SY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):258-60. PubMed ID: 12764905 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of the biological characteristics of infant acute leukemia]. Ma XL; Wu MY; Zhang YH Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):128. PubMed ID: 19538890 [No Abstract] [Full Text] [Related]
17. Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia. Lambertenghi-Deliliers G; Annaloro C; Cortelezzi A; Cortellaro M; Della Volpe A; Maiolo AT; Mozzana R; Pogliani E; Pozzoli E; Polli EE Semin Oncol; 1989 Feb; 16(1 Suppl 2):16-20. PubMed ID: 2928806 [No Abstract] [Full Text] [Related]
18. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia. Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630 [TBL] [Abstract][Full Text] [Related]
19. [Our experience in the treatment of adult acute leukemias in the past 5 years]. Nomura T; Dan K; Tajika K Nihon Ika Daigaku Zasshi; 1988 Dec; 55(6):603-7. PubMed ID: 3209675 [No Abstract] [Full Text] [Related]
20. Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia. Lunghi M; Riccomagno P; De Paoli L; Vendramin C; Conconi A; Gaidano G; Rossi D Am J Hematol; 2009 Oct; 84(10):697-8. PubMed ID: 19691101 [No Abstract] [Full Text] [Related] [Next] [New Search]